WebJan 6, 2024 · In corneal health, Glaukos’ proprietary suite of single-use, bio-activated pharmaceuticals are designed to strengthen, stabilize and reshape the cornea through a process called corneal collagen cross-linking to treat corneal ectatic disorders and correct refractive conditions. WebJan 11, 2024 · iPrime is a sterile, single-use, minimally invasive product designed to deliver viscoelastic fluid during eye surgeries. A pioneer in minimally invasive glaucoma surgery, …
FDA clears Glaukos’ iPrime - MassDevice
WebJan 7, 2024 · Glaukos (NYSE:GKOS) announced that it received FDA 510(k) clearance for its iPrime viscodelivery system. San Clemente, California-based Glaukos designed the Prime … WebJan 6, 2024 · Glaukos Corporation (NYSE: GKOS), today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the iPRIME™ … black white light bulb
QUICK HITS - Ophthalmology Management
WebJan 7, 2024 · Glaukos (NYSE:GKOS) announced that it received FDA 510(k) clearance for its iPrime viscodelivery system. San Clemente, California-based Glaukos designed the Prime viscodelivery system as a sterile,... WebJan 6, 2024 · Glaukos Corporation (NYSE:GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today ... WebAug 4, 2024 · The system is intended for use in standalone surgery for patients with primary open-angle glaucoma whose increased intraocular pressure (IOP) is uncontrolled by … black white lighthouse